GPAT Income Tax Expense from 2010 to 2025

GPAT Stock   10.42  0.02  0.19%   
GP Act Income Tax Expense yearly trend continues to be comparatively stable with very little volatility. Income Tax Expense will likely drop to about -17 K in 2025. From the period from 2010 to 2025, GP Act Income Tax Expense quarterly data regression had r-value of  0.67 and coefficient of variation of (21.86). View All Fundamentals
 
Income Tax Expense  
First Reported
2010-12-31
Previous Quarter
-16.1 K
Current Value
-17 K
Quarterly Volatility
6.1 K
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check GP Act financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among GP Act's main balance sheet or income statement drivers, such as Other Operating Expenses of 17.9 K, Ebitda of 9.1 M or Total Operating Expenses of 593.2 K, as well as many indicators such as Price To Sales Ratio of 0.0, Dividend Yield of 0.0 or PTB Ratio of 0.62. GPAT financial statements analysis is a perfect complement when working with GP Act Valuation or Volatility modules.
  
Build AI portfolio with GPAT Stock
Check out the analysis of GP Act Correlation against competitors.

Latest GP Act's Income Tax Expense Growth Pattern

Below is the plot of the Income Tax Expense of GP Act III Acquisition over the last few years. It is GP Act's Income Tax Expense historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in GP Act's overall financial position and show how it may be relating to other accounts over time.
Income Tax Expense10 Years Trend
Slightly volatile
   Income Tax Expense   
       Timeline  

GPAT Income Tax Expense Regression Statistics

Arithmetic Mean(28,007)
Geometric Mean27,164
Coefficient Of Variation(21.86)
Mean Deviation4,610
Median(30,844)
Standard Deviation6,124
Sample Variance37.5M
Range16.8K
R-Value0.67
Mean Square Error22.3M
R-Squared0.45
Significance0
Slope859.17
Total Sum of Squares562.5M

GPAT Income Tax Expense History

2025-17 K
2024-16.1 K
2023-14 K

About GP Act Financial Statements

GP Act shareholders use historical fundamental indicators, such as Income Tax Expense, to determine how well the company is positioned to perform in the future. Although GP Act investors may analyze each financial statement separately, they are all interrelated. The changes in GP Act's assets and liabilities, for example, are also reflected in the revenues and expenses on on GP Act's income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.
Last ReportedProjected for Next Year
Income Tax Expense-16.1 K-17 K

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Additional Tools for GPAT Stock Analysis

When running GP Act's price analysis, check to measure GP Act's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy GP Act is operating at the current time. Most of GP Act's value examination focuses on studying past and present price action to predict the probability of GP Act's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move GP Act's price. Additionally, you may evaluate how the addition of GP Act to your portfolios can decrease your overall portfolio volatility.